Jake Simson
InvestorPartner at RA Capital
Cambridge, Massachusetts
Writes $100K – $5M checks · typically $1.5M
FoundedConvergent TherapeuticsOutpace BioVivace Therapeutics
Experience
- RA Capital Management, L.P.Partnercurrent2020 — presentGreater Boston
- RA Capital Management, LLCPrincipal2017 — 2020Greater Boston
- RA Capital Management, LLCAnalyst2015 — 2017Boston
- RA Capital Management, LLCAssociate2013 — 2015Boston
- Johns Hopkins University Translational Tissue Engineering CenterPhD Candidate2008 — 2013Baltimore, MD
Education
- The Johns Hopkins UniversityPhD, Biomedical Engineering2008 — 2013
- Massachusetts Institute of Technology2004 — 2008
Skills & more
BiomaterialsConfocal MicroscopyStem CellsCell CultureBiomedical EngineeringTissue EngineeringMicrofluidics
From Jake's professional profile.
Same school
Also attended The Johns Hopkins University213
Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesCaitlinChief of Staff at Hummingbird VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General Catalyst
+ 207 more
Also attended Massachusetts Institute of Technology989
Fred WilsonCo-founder & Partner at Union Square VenturesAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of Varda
+ 983 more
Shared employers
Also worked at Johns Hopkins University Translational Tissue Engineering Center47
Demi ObayomiPrincipal at Sapphire VenturesCaitlinChief of Staff at Hummingbird VenturesJun JeonInvestor at Khosla VenturesLinda CuretonBoard Member at Maryland TEDCODavid NarrowVenture Advisor at Cultivation CapitalCharlie BuffaVice President, Sales at Mainsail Partners
+ 41 more
Deals · 4
Outpace BioBoard seat
via RA Capital · filed Aug 2024 · $144.2M raise
SepternaBoard seat
via RA Capital · filed Jul 2023 · $150M raise
Convergent TherapeuticsBoard seat
via RA Capital · filed May 2023 · $99.2M raise
DiCE Molecules HoldingsBoard seat
via RA Capital · filed Jan 2021 · $81.5M raise
Attribution from SEC filings, press coverage, and firm rosters.



















